Chemicals and pharmaceuticals · IBO

IMPACT BIOMEDICAL INC.

4 filings mentioning 4 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

4filings we hold
4topics disclosed
Chemicals and pharmaceuticalsindustry
TXbased in

Across 4 filings we hold, IMPACT BIOMEDICAL INC. has written down 4 of the topics we track. That places it 618 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

TopicFilingsMost recent
Identity And Access Management32026-03-11
Regulatory Reporting32026-03-11
Internal Control12025-06-23
Material Weakness12025-06-23

When it filed

Filings we hold, by year. Hover a bar for the count.

24
25
26

Recent filings

FiledFormItem
2026-03-1110-Kfiling
2025-06-238-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2025-03-2810-Kfiling
2024-02-2010-Kfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition